Rare Disease Day
Watch our Rare Disease Day film to see the highlights of the day and understand the reasons why we support this important annual event.
2017 theme: Research brings hope to people living with a rare disease
If a disease is rare, should we invest in research to find a treatment? This is a problem facing over 3,000,000 people in England (24 million in Europe) because there are thousands of rare diseases. Although each rare disease affects less than one in 2,000 people, those who are affected suffer on a daily basis due to a lack of knowledge about their rare diseases and often only receive treatment for their symptoms with little hope of recovering from the disease.
On 24 February 2017, Royal Holloway ran it's annual Rare Disease Day event (alongside the international Rare Disease Day) raising awareness of rare diseases and the millions of families who are affected by them. The event included a range of talks, activities and exhibitions.
A big thank you to everyone who attended and helped with the running of Rare Disease Day 2017 - it was a huge success!
The full list of speakers, events and activities can be found here.
View the talks given on the day
- Welcome, Professor John Wann
- Introduction to Rare Disease Day, Professor Rafael Yáñez
- Syndromes Without A Name - the challenges of having an undiagnosed genetic condition, Lauren Roberts
- Living with Ataxia Telangiectasia (A-T), Sean Kelly
- Oculopharyngeal Muscular Dystrophy, Dr Alberto Malerba
Our 2017 exhibitors
Action for A-T
Ashford and St. Peter's Hospitals
Barbara Zipser, Hellenic Institute, Department of History
Genetic Alliance UK
Genetic Disorders UK
Muscular Dystrophy UK
Spinal Muscular Atrophy Support UK
The British Society for Gene and Cell Therapy
The Fragile X Society
The Ichthyosis Support Group
The SMA Trust
Tuberous Sclerosis Association
About rare diseases research at Royal Holloway
Royal Holloway is a leading institution in the development of novel therapies for rare diseases, including Spinal muscular atrophy, Spinal injury, Severe combined immunodeficiency (referred to as ‘child in a bubble’ disease) and Duchenne muscular dystrophy. Our scientists in the School of Biological Sciences are at the forefront in developing innovative techniques in gene and cell therapy. Much of this research is carried out in the labs of our RDD organiser Professor Rafael Yáñez and co-organiser Professor George Dickson.